Toggle navigation
Home
Search
Services
Blog
Contact
About
Toward a Molecularly-Defined Vaccine for Schistosomiasis
Loverde, Philip T.
State University of New York at Buffalo, Buffalo, NY, United States
Search 76 grants from Philip Loverde
Search grants from State University of New York at Buffalo
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Cellular regulation of cochlear blood flow
Dual Gene Therapy for Heart Failure
Nervous System Regeneration and Plasticity
Adolescent Medicine HIV/AIDS Research Network
Structure and Stabilization of the Bacterial Nucleoid
Recently added grants:
Mexican American Drinking Contexts On and Away from the U.S./Mexico Border
Social Ecological Contexts of Heavy Drinking and Alcohol Use Disorders
Role of SAP30 in hypoxia inducible factor activation and breast cancer progression
Framework for Behavioral Risk Models of Alcohol Problems
Mre11-Dependent DNA Damage Responses in Breast Cancer Pathogenesis
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI018867-09
Application #
3128255
Study Section
Tropical Medicine and Parasitology Study Section (TMP)
Project Start
1983-04-01
Project End
1994-06-30
Budget Start
1991-07-01
Budget End
1992-06-30
Support Year
9
Fiscal Year
1991
Total Cost
Indirect Cost
Institution
Name
State University of New York at Buffalo
Department
Type
Schools of Dentistry
DUNS #
038633251
City
Buffalo
State
NY
Country
United States
Zip Code
14260
Related projects
Publications
Corstjens, Paul L A M; De Dood, Claudia J; Kornelis, Dieuwke et al.
(2014)
Tools for diagnosis, monitoring and screening of Schistosoma infections utilizing lateral-flow based assays and upconverting phosphor labels.
Parasitology 141:1841-55
Comments
Be the first to comment on Philip Loverde's grant